Patents Assigned to BIOSIRIUS LTD
  • Publication number: 20230192838
    Abstract: The present invention relates to pharmaceutical compositions and methods for the treatment of viral respiratory infections. More specifically, the present invention relates to IL-18 antagonists and their use in the treatment of a viral respiratory infection in a subject having: (a) a deficiency of IL-18 binding protein; and/or (b) a deficiency of natural killer cells and/or a deficiency of functional natural killer cells.
    Type: Application
    Filed: May 19, 2021
    Publication date: June 22, 2023
    Applicant: BIOSIRIUS LTD
    Inventor: Syed Muhammad Tahir NASSER